119 related articles for article (PubMed ID: 37018994)
1. Synergistic anti-cancer and attenuation effects of thymosin on chemotherapeutic drug vinorelbine in tumor-bearing zebrafish.
Wang S; Wei W; Yong H; Zhang Z; Zhang X; Zhang X; Wang S
Biomed Pharmacother; 2023 Jun; 162():114633. PubMed ID: 37018994
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of thymosin beta 10 inhibiting the apoptosis
and prompting proliferation in A549 cells].
Li Z; Qu L; Zhong H; Xu K; Qiu X
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):783-8. PubMed ID: 25404268
[TBL] [Abstract][Full Text] [Related]
3. [Effect and mechanism of aspirin combined with vinorelbine on non-small cell lung cancer].
Cui L; Qiu YN; Xu Y; Teng YO; Yu P; Liu Z
Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(24):6012-6019. PubMed ID: 33496142
[TBL] [Abstract][Full Text] [Related]
4. Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses.
Gameiro SR; Caballero JA; Higgins JP; Apelian D; Hodge JW
Cancer Immunol Immunother; 2011 Sep; 60(9):1227-42. PubMed ID: 21544650
[TBL] [Abstract][Full Text] [Related]
5. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
Matsumoto S; Igishi T; Hashimoto K; Kodani M; Shigeoka Y; Nakanishi H; Touge H; Kurai J; Makino H; Takeda K; Yasuda K; Hitsuda Y; Shimizu E
Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
[TBL] [Abstract][Full Text] [Related]
6. [Anti-angiogenic effect of vinorelbine in combination with cetuximab in vitro and in vivo].
Qian XP; Liu BR; Wan L; Hu J; Zhu LJ; Yu LX
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):253-7. PubMed ID: 20510073
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel Agents on Spindle Assembly Checkpoint to Sensitize Vinorelbine-Induced Mitotic Cell Death Against Human Non-Small Cell Lung Cancers.
Chang YC; Tseng YL; Leu WJ; Du CM; Jiang YH; Hsu LC; Hsu JL; Hou DR; Guh JH
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764382
[TBL] [Abstract][Full Text] [Related]
8. Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform.
Liang Z; Li J; Zhu B
Drug Des Devel Ther; 2020; 14():4519-4531. PubMed ID: 33149550
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
Webb MS; Johnstone S; Morris TJ; Kennedy A; Gallagher R; Harasym N; Harasym T; Shew CR; Tardi P; Dragowska WH; Mayer LD; Bally MB
Eur J Pharm Biopharm; 2007 Mar; 65(3):289-99. PubMed ID: 17123800
[TBL] [Abstract][Full Text] [Related]
11. Synergy between vinorelbine and afatinib in the inhibition of non-small cell lung cancer progression by EGFR and p53 signaling pathways.
Liu Z; Fu Q; Wang Y; Cui L; Zhang W; Teng Y; Yu P
Biomed Pharmacother; 2021 Feb; 134():111144. PubMed ID: 33360044
[TBL] [Abstract][Full Text] [Related]
12. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
13. Thymosin α-1 in cancer therapy: Immunoregulation and potential applications.
Wei Y; Zhang Y; Li P; Yan C; Wang L
Int Immunopharmacol; 2023 Apr; 117():109744. PubMed ID: 36812669
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer.
Schulof RS; Lloyd MJ; Cleary PA; Palaszynski SR; Mai DA; Cox JW; Alabaster O; Goldstein AL
J Biol Response Mod; 1985 Apr; 4(2):147-58. PubMed ID: 3998766
[TBL] [Abstract][Full Text] [Related]
15. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
[TBL] [Abstract][Full Text] [Related]
16. Thymosin beta 4 synergizes with human granulocyte-macrophage colony-stimulating factor in maintaining bone marrow proliferation.
Moscinski LC; Naylor PH; Oliver J; Goldstein AL
Immunopharmacology; 1993; 26(1):83-92. PubMed ID: 8407287
[TBL] [Abstract][Full Text] [Related]
17. Immunopharmacology of thymosin alpha1 and cytokine synergy.
Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.
Menendez JA; Colomer R; Lupu R
Oncol Rep; 2004 Aug; 12(2):411-22. PubMed ID: 15254710
[TBL] [Abstract][Full Text] [Related]
19. [Primary assessment of treatment effect of thymosin alpha1 on chemotherapy-induced neurotoxicity].
An TT; Liu XY; Fang J; Wu MN
Ai Zheng; 2004 Nov; 23(11 Suppl):1428-30. PubMed ID: 15566650
[TBL] [Abstract][Full Text] [Related]
20. Mechanism and clinical application of thymosin in the treatment of lung cancer.
Liu Y; Lu J
Front Immunol; 2023; 14():1237978. PubMed ID: 37701432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
